Annexon, Inc.
ANTI-COMPLEMENT FACTOR C1Q ANTIBODIES AND USES THEREOF

Last updated:

Abstract:

The present invention provides anti-C1q antibodies and methods of using the same.

Status:
Application
Type:

Utility

Filling date:

10 Feb 2021

Issue date:

9 Sep 2021